Melarsoprol
Formulations: - Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound) Indications: - Gambiense trypanosomiasis - Rhodesiense trypanosomiasis Source: EML workbook import
MOQ: 1
Kes0.00
Vendor: Marketplace supplier
Product metadata will be available once the catalog entry is complete.
Formulations: - Parenteral > General injections > IV: 3.6% in 5 mL ampoule solution (180 mg of active compound) Indications: - Gambiense trypanosomiasis - Rhodesiense trypanosomiasis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 100 µg per mL (heat stable) Indications: - Postpartum haemorrhage Source: EML workbook import
Formulations: - Oral > Solid: 50 mg Indications: - Thyrotoxicosis Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.